Article Versions Notes

Piao HH, Jeon S, Yoo SW, Ryu YJ, Kim D-Y, Pyo A, Bom H-S, Min J-J, Kwon SY. A Stepwise Approach Using Metastatic Lymph Node Ratio-Combined Thyroglobulin for Customization of [¹⁸F]FDG-PET/CT Indication to Detect Persistent Disease in Patients with Papillary Thyroid Cancer. Diagnostics. 2021; 11(5):836. https://doi.org/10.3390/diagnostics11050836

Piao, Hong Hua, Subin Jeon, Su Woong Yoo, Young Jae Ryu, Dong-Yeon Kim, Ayoung Pyo, Hee-Seung Bom, Jung-Joon Min, and Seong Young Kwon. 2021. "A Stepwise Approach Using Metastatic Lymph Node Ratio-Combined Thyroglobulin for Customization of [¹⁸F]FDG-PET/CT Indication to Detect Persistent Disease in Patients with Papillary Thyroid Cancer" Diagnostics 11, no. 5: 836. https://doi.org/10.3390/diagnostics11050836

Piao, H. H., Jeon, S., Yoo, S. W., Ryu, Y. J., Kim, D. -Y., Pyo, A., Bom, H. -S., Min, J. -J., & Kwon, S. Y. (2021). A Stepwise Approach Using Metastatic Lymph Node Ratio-Combined Thyroglobulin for Customization of [¹⁸F]FDG-PET/CT Indication to Detect Persistent Disease in Patients with Papillary Thyroid Cancer. Diagnostics, 11(5), 836. https://doi.org/10.3390/diagnostics11050836